Discovery of SLC3A2 Cell Membrane Protein as a Potential Gastric Cancer Biomarker: Implications in Molecular Imaging by Yixuan Yang (510257)

“…Immunofluorescence and immunohistochemistry both confirmed the plasma membrane localization of SLC3A2 in gastric cancer cells. The data supported the notion that SLC3A2 is a potential biomarker that could be exploited for molecular imaging-based detection of gastric cancer.…”

Post-ischemic treatment with HDL does not decrease oxidation. by Marie-Claude Brulhart-Meynet (703281)

Less Iso-induced decrease of τ in female hearts. by Gregory S. Hoeker (650231)

“…B) Sex differences in the decrease in τ (versus baseline values) as a function of the dose of Iso (1, 10, 31.6, 100, 316.2 nM) in the LV base <i>(left)</i> and apex <i>(right)</i> of female (n = 5) and male (n = 5) hearts with pacing at 3 (<i>top</i>) and 5.5 Hz (<i>bottom</i>). …”

Decrease of muscle weakness and degeneration with mutants of UPS components. by Cécile Ribot (11944875)

Androgen Receptor and Histone Lysine Demethylases in Ovine Placenta by Ellane R. Cleys (692077)

“…AR co-immunoprecipitated with KDM1A and KDM4D in sheep placentomes, and AR-KDM1A complexes were recruited to a half-site for androgen response element (ARE) in the promoter region of <i>VEGFA</i>. …”

THS exposure results in hyperglycemia and decrease in insulin sensitivity. by Manuela Martins-Green (516426)

“…<p>(<b>A</b>) Fasting glucose levels of mice exposed to THS were significantly increased in comparison to control. …”

Intent to decrease use of OTC NSAIDs and NSAID exposure. by Matthew G. Vinson (22593374)

“…<p>(A) Scatter plot of the group effect on intent to decrease use of OTC NSAIDs at pre-intervention and post-intervention. …”

Meiotic recombination levels decrease with successive generations of exposure. by Tegan S. Horan (4261393)

MASL targets PDPN to decrease cell migration and viability. by Jhon Alberto Ochoa-Alvarez (315051)

Expression of miR-34a-5p is up-regulated in human colorectal cancer and correlates with survival and clock gene <i>PER2</i> expression by Kristina Hasakova (7553306)

“…High miR-34a expression was associated with better survival of patients. miR-34a showed lower expression levels in male patients with lymph node involvement, and a trend towards decreased expression in male patients with distant metastases. …”

Presentation_1_Attenuated Duck Hepatitis A Virus Infection Is Associated With High mRNA Maintenance in Duckling Liver via m6A Modification.pdf by Liping Wu (578606)

“…GO analysis of genes with decreased or increased m6A levels showed that these genes were enriched in various terms, including oxidation–reduction processes and antiviral immune responses. …”

Loss of <i>Tuba1a</i> leads to altered patterns of neurogenesis and migration. by Elizabeth Bittermann (7140338)

“…In comparison to wild-type cells at E14.5 (n = 4 wild-type and mutant embryos), the number of <i>Tuba1a</i> mutant total EdU+ cells are reduced (K), EdU-Ki67+ cells are increased (L), EdU+Ki67+ cells are increased (M) and the quit fraction (EdU+Ki67-/EdU+) is decreased (N). …”

MCSF-1 and MMP-9 decrease with EGFR inhibition. by Nicole K. Nickerson (187328)

The Protective Effect of Esculentoside A on Experimental Acute Liver Injury in Mice by Fang Zhang (197215)

“…In addition, levels of AST and ALT were significantly decreased by EsA treatment. Furthermore, the mice treated with EsA had a lower level of TNF-α, Interleukin (IL)-1β and IL-6 in mRNA expression. …”

DataSheet_1_Depletion of the m1A writer TRMT6/TRMT61A reduces proliferation and resistance against cellular stress in bladder cancer.docx by Ida Monshaugen (13109619)

“…The average cell displacement of 5637 was also reduced upon TRMT6/TRMT61A depletion. Interestingly, TRMT6/TRMT61A depletion decreased mRNA expression of targets associated with the ATF6-branch of the UPR in 5637 but not in HT1197. …”

Decrease levels of selected transcripts after bacterial death. by Claire Cenciarini (270021)

PROFILE OF PATIENTS WITH OSTEOPOROTIC FRACTURES AND FACTORS THAT DECREASE PREVENTION by Renato Martins Xavier (6544958)

Sharp decrease in infection incidence between 2007 and 2008. by Denis Valle (197557)

Explaining the Decrease of In-Hospital Mortality from Ischemic Stroke by Jens Minnerup (9004)

“…Use of in-hospital treatments including antiplatelets within 48 hours, antihypertensive therapy, statins, antidiabetics, physiotherapy and anticoagulants increased over time and was significantly associated with a decrease in mortality. The association of the year of admission with mortality became insignificant after adjustment for antiplatelet therapy within 48 hours (from OR 0.96; 95% CI, 0.94-0.98, to OR 0.99; 95% CI, 0.97-1.01) and physiotherapy (from OR 0.96; 95% CI, 0.94-0.97, to OR 0.99; 95% CI, 0.97-1.00).…”

B-THP-Ts decrease cellular ATP levels. by Lindsay B. Tulloch (1266861)